血清miR-218作为局部晚期宫颈癌同步放化疗反应及预后标志物的临床价值

血清miR-218作为局部晚期宫颈癌同步放化疗反应及预后标志物的临床价值

PDF(1734 KB)

PDF(1734 KB)

Journal of Guangxi Medical University ›› 2022, Vol. 39 ›› Issue (11) : 1766-1772. DOI: 10.16190/j.cnki.45-1211/r.2022.11.013

Author information +

History +

CLC number

R737.33

Cite this article

Download Citations

Comments

PDF(1734 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉